Thirty-seven organizations representing manufacturers, health plans and insurers, pharmacy benefit managers, corporate employers, consumers, and patients have banded together to support and hopefully reinvigorate action to pass the bicameral Biosimilar Red Tape Elimination Act. The Biosimilar Red Tape Elimination Act has been long-awaited, but it is not making much progress through Congress. As of January … Continue reading An Injection of Support for the Biosimilar Red Tape Elimination Act